Rchr
J-GLOBAL ID:201801015866656954   Update date: Feb. 02, 2024

Akaike Keisuke

アカイケ ケイスケ | Akaike Keisuke
Affiliation and department:
Research field  (1): Orthopedics
Research theme for competitive and other funds  (2):
  • 2019 - 2023 遺伝子制御部位に注目した高悪性度紡錘形細胞肉腫の遺伝子発現解析と新規治療法開発
  • 2017 - 2019 Developement of new therapy for high-grade sarcoma focused on dephosphorylation disorder
Papers (80):
  • Keita Sasa, Raku Son, Akiko Oguchi, Karin Ashizawa, Nobuhiko Hasegawa, Daisuke Kubota, Yoshiyuki Suehara, Tatsuya Takagi, Taketo Okubo, Keisuke Akaike, et al. NTRK2 expression in gastrointestinal stromal tumors with a special emphasis on the clinicopathological and prognostic impacts. Scientific reports. 2024. 14. 1. 768-768
  • Keita Sasa, Tsuyoshi Saito, Taisei Kurihara, Nobuhiko Hasegawa, Kei Sano, Daisuke Kubota, Keisuke Akaike, Taketo Okubo, Takuo Hayashi, Tatsuya Takagi, et al. Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma (Discover Oncology, (2021), 12, (57), 10.1007/s12672-021-00453-2). Discover Oncology. 2022. 13. 1
  • Keita Sasa, Tsuyoshi Saito, Taisei Kurihara, Nobuhiko Hasegawa, Kei Sano, Daisuke Kubota, Keisuke Akaike, Taketo Okubo, Takuo Hayashi, Tatsuya Takagi, et al. Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma. Discover. Oncology. 2022. 13. 1. 20-20
  • Keita Sasa, Tsuyoshi Saito, Taisei Kurihara, Nobuhiko Hasegawa, Kei Sano, Daisuke Kubota, Keisuke Akaike, Taketo Okubo, Takuo Hayashi, Tatsuya Takagi, et al. Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma. Technology in cancer research & treatment. 2022. 21. 15330338221138217-15330338221138217
  • Keita Sasa, Tsuyoshi Saito, Taisei Kurihara, Nobuhiko Hasegawa, Kei Sano, Daisuke Kubota, Keisuke Akaike, Taketo Okubo, Takuo Hayashi, Tatsuya Takagi, et al. IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma. Discover Oncology. 2021. 12. 1
more...
MISC (104):
  • 吉田 司, 三浦 季余美, 北原 エリ子, 伊澤 奈々, 安藤 純, 赤池 慶祐, 高木 辰哉, 水嶋 章郎, 藤原 俊之. 対麻痺発症後、多発性骨髄腫と診断された症例に対するリハビリテーション. Palliative Care Research. 2020. 15. Suppl. S537-S537
  • Taisei Kurihara, Yoshiyuki Suehara, Keisuke Akaike, Takuo Hayashi, Shinji Kohsaka, Nobuhiko Hasegawa, Tatsuya Takagi, Taketo Okubo, Youngji Kim, Takashi Yao, et al. Detection of Fusion Genes in Inflammatory Myofibroblastic Tumor/Inflammatory Pseudotumor by Nanostring-Based Screening System. LABORATORY INVESTIGATION. 2020. 100. SUPPL 1. 59-60
  • Taisei Kurihara, Yoshiyuki Suehara, Keisuke Akaike, Takuo Hayashi, Shinji Kohsaka, Nobuhiko Hasegawa, Tatsuya Takagi, Taketo Okubo, Youngji Kim, Takashi Yao, et al. Detection of Fusion Genes in Inflammatory Myofibroblastic Tumor/Inflammatory Pseudotumor by Nanostring-Based Screening System. MODERN PATHOLOGY. 2020. 33. SUPPL 2. 59-60
  • 佐野圭, 末原義之, 佐々恵太, 林大久生, 栗原大聖, 石井翠, 赤池慶祐, 金栄智, 大久保武人, 高木辰哉, et al. 滑膜肉腫プロテオミクス解析に基づいたHSP90に対する新規治療開発. 日本整形外科学会雑誌. 2020. 94. 2
  • 佐々恵太, 末原義之, 佐野圭, 栗原大聖, 石井翠, 金栄智, 赤池慶祐, 大久保武人, 林大久生, 齋藤剛, et al. Gastrointestinal stromal tumorの手術検体とc-kit発現調節を行った細胞株とのタンパク質発現解析とHPS90を標的とした治療開発. 日本整形外科学会雑誌. 2020. 94. 2
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page